Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) [Phase 1, Phase 2]
ELU001, studied in Phase 1/2 in FRα-overexpressing solid tumors, has been terminated.
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating AK-104, a PD-1/CTLA-4 bispecific antibody, in combination with chemotherapy as neoadjuvant treatment for advanced…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial investigating two standard doses of bevacizumab in combination with chemotherapy for epithelial ovarian cancer, including pl…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants [Phase 1, Phase 2]
Phase 1/2 study evaluating ASP0739 alone and in combination with pembrolizumab in NY-ESO-1 expressing advanced solid tumors was terminated, …
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer [Phase 1, Phase 2]
This clinical trial update reports the termination of the Phase 1/2 study QUILT-3.040 evaluating ETBX-011 vaccine in combination with ALT-80…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients
A prospective, multi-center, real-world study of patients with ovarian metastasis from colorectal cancer, sponsored by West China Hospital, …
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Exercise Effect on Chemotherapy-Induced Neuropathic Pain [NA]
Clinical trial update on a study examining whether exercise can affect chemotherapy-induced neuropathic pain in cancer patients. The trial s…
-
CLINICAL_TRIALS other · 2024-08-06Clinical Trial Update: Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating maintenance therapy with Fluzoparib in combination with Apatinib Mesylate for stage III-IV ovarian cance…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
This clinical trial compares intraperitoneal chemotherapy with intravenous chemotherapy for recurrent ovarian cancer, and it is not yet recr…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data
Clinical trial update describing a PET-CT image-based predictive model to forecast satisfactory debulking in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast [Phase 1]
Phase 1 study evaluating safety and tolerability of combining Niraparib with Everolimus in advanced gynecologic malignancies and breast canc…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: A Study of XS-02 Capsules in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update covers XS-02 capsules in advanced solid tumors (including ovarian, breast, and endometrial cancers) in Phase 1/2,…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies [Phase 1, Phase 2]
This clinical trial update reports dose-escalation and preliminary efficacy findings for intratumoral mRNA-2416 as a standalone therapy and …
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Study of PF-06873600 in People With Cancer [Phase 1, Phase 2]
Pfizer's PF-06873600 in Phase 1/2 for several cancers was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer
This clinical trial update describes a study on mesenteric lymph node metastasis and nutritional status after bowel resection in ovarian can…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers [Phase 1]
Phase 1 clinical trial evaluating nab-paclitaxel in combination with bevacizumab in patients with unresectable stage IV melanoma or gynecolo…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension
A clinical trial update examining whether antihypertensive therapy affects recurrence risk in ovarian cancer patients receiving bevacizumab-…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety and tolerability study of NC410 in advanced or metastatic solid tumors has been terminated, with results posted in 2024, in…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: First-in-Human Dose Expansion Study of XMT-1536 in Cancers Likely to Express NaPi2b [Phase 1]
First-in-human dose expansion Phase 1 trial of XMT-1536 targeting NaPi2b in cancers likely to express the transporter, including platinum-re…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for UCMYM802 Injection in mesothelin-positive advanced malignant solid tumors, listing several cance…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Plasmodium Immunotherapy for Advanced Ovarian Cancer [Phase 2, Phase 3]
A clinical trial update for a Plasmodium-based immunotherapy in advanced ovarian cancer, spanning Phase 2 and Phase 3, with enrollment not y…
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: A Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update describes a study of QL1706 combined with albumin-bound paclitaxel and bevacizumab for platinum-resistant re…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating COM701 in combination with BMS-986207 and nivolumab in adults with advanced solid tumors, including e…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
This clinical trial update describes a study assessing minimal residual disease in ovarian cancer using circulating tumor DNA and immune rep…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
Clinical trial update on personalized ctDNA-based minimal residual disease (MRD) assessment in cervical cancer, sponsored by Geneplus-Beijin…